Supportive Care News & Features
CTA spoke with Judith A. Paice, PhD, RN, to better understand how clinicians are reacting to these legalizations and how she responds to patients asking about cannabis use.
Parents of children diagnosed with cancer are likely to have long-lasting income reductions, regardless of sociodemographic factors before diagnosis.
In screening for mood disorders among patients with cancer, the PHQ-2 diagnostic tool demonstrates effective psychometric properties.
Financial hardship is common among cancer survivors in the US, and can be a psychologically and economically debilitating burden.
Many patients with cancer who receive intravenous chemotherapy who are at low emetic risk may receive unnecessary prophylactic antiemetic drug treatment.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated.
Despite the availability of palliative and supportive care at major cancer centers, patients may encounter barriers to accessing these services.
The early integration of palliative care shortly after diagnosis of some incurable cancers improves both a patient's coping abilities and overall quality of life.
The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.
Continuous deep sedation (CDS) should be considered a viable option for patients with advanced cancer being cared for in a palliative setting.
Researchers claim that systems medicine could reduce cardiovascular toxicity caused by TKI therapy.
Patients with multiple myeloma have similar survival outcomes whether they are treated with thalidomide or lenalidomide.
Androgen deprivation therapy (ADT) use among patients with prostate cancer was not associated with an increased risk of dementia
These toxicities are rare, though it is unclear how physicians can screen for them.
Treatment-related select adverse events of any grade were associated with higher overall response rate.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Watson: A Glorified Search Engine?
- Is Drugmaker Funding for Patient Groups a Hidden Culprit in Rising Drug Prices?
- Nivolumab + Ibrutinib Active in Relapsed/Refractory CLL and Richter Transformation
- Study Identifies Ultra-high Risk Category of Patients With DLBCL
- TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
- Study Highlights Importance of Achieving CR After Intensive Therapy for AML
- No Induction Therapy Superior to Another for Higher-risk AML, MDS
- Condensed HDAC Schedule Superior to Standard Schedule in AML
- Higher Idarubicin Dose During Consolidation Improves Leukemia-free Survival in AML
- Brentuximab Vedotin Superior to Standard of Care Options in CTCL